WAYNE, Pa.--(BUSINESS WIRE)--Jan. 18, 2019--
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical
technologies with solutions in the fields of vascular and interventional
access, surgical and cardiac care, will showcase the MANTA™ Vascular
Closure Device as well as its portfolio for peripheral interventions at
the Annual Meeting of the Leipzig Interventional Course (LINC) 2019, in
Leipzig, Germany.
With the acquisition of Essential Medical, Inc., Teleflex now offers the
CE Marked MANTA™ Vascular Closure Device specifically designed for
closure of large bore arteriotomies following procedures utilizing
devices or sheaths ranging in size from 10F to 18F (with maximum outer
diameters up to 25F). In its CE Mark study, the MANTA™ Device
demonstrated rapid and reliable hemostasis with its resorbable
collagen-based technology and complication rates that were similar to
surgical and suture-based closure methods.1
Clinicians worldwide rely on the quality and proven clinical utility of
our peripheral intervention portfolio with products such as Turnpike®
Catheters, Supercross® Microcatheters, the Pronto®
Extraction Catheter, Micro Elite™ and Expro Elite™ Snares and the
Hunter™ Biopsy Sealing Device. The MANTA™ Vascular Closure Device is not
commercially available in the United States.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to
improve the health and quality of people’s lives. We apply purpose
driven innovation - a relentless pursuit of identifying unmet clinical
needs - to benefit patients and healthcare providers. Our portfolio is
diverse, with solutions in the fields of vascular and interventional
access, surgical, anesthesia, cardiac care, urology, emergency medicine
and respiratory care. Teleflex employees worldwide are united in the
understanding that what we do every day makes a difference. For more
information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson
RCI®, LMA®, Pilling®, Rüsch®,
UroLift® and Weck® – trusted brands united by a
common sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
References:
1. Van Mieghem NM, Latib A, van der Heyden J, van Gils L, et al.
Percutaneous Plug-Based Arteriotomy Closure Device for Large-Bore
Access: A Multicenter Prospective Study. JACC: Cardiovasc Intervent.
2017;10(6):613-619.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190118005002/en/
Source: Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
Emmet Dalton
Director of Marketing Communications International
M:
+353 87 333 3262
E: emmet.dalton@teleflex.com